Technology Improves Neural Imaging, Human Brain Research

Source: Laboratory Equipment (4/2/12)

"A new cost-effective neural imaging system allows researchers to make much more complex maps of the brain with just one camera and one imaging system."

Laboratory Equipment

Neural imaging—maps of brain functions—is a primary tool used by researchers hoping to transform the lives of people living with chronic neurological conditions such as epilepsy. At present, researchers often require several different imaging techniques to fully map brain functions, making research and treatment of these conditions expensive and inefficient.

Using cutting-edge illumination technology, Prof. Ofer Levi and his research students from the Institute of Biomaterials & Biomedical Engineering (IBBME) and The Edward S. Rogers Sr. Department of Electrical & Computer Engineering (ECE) at the Univ. of Toronto has developed a new cost-effective neural imaging system. It allows researchers to make much more complex maps of the brain with just one camera and one imaging system. The team's initial findings, released this week in Biomedical Optics Express, demonstrate that this new technology may one day transform the way researchers view the human brain.

Developed from the same technology that lights up our cell phones and computers, this unique system uses Vertical Cavity Surface Emitting Lasers (VCSEL): low-cost, easily-tested, miniature microchip lasers mounted on an extremely fast, sensitive camera, which allows the operator to switch the lasers on and off with extraordinary speed and precision. This rapid light manipulation (at a rate of approximately 1x/millisecond) means that the brain can be mapped with greater sophistication and precision—much more quickly. Results published in Levi's article, for instance, demonstrate that this imaging technology is able to classify both veins and arteries simultaneously—something never before accomplished. . .View Full Article

Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (01/28/2021)

Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.

Imagin Medical Is Bringing Cystoscopy into the 21st Century
Source: Dr. KSS, MD, PhD, for Streetwise Reports (01/21/2021)

Dr. KSS, MD, PhD, editor-in-chief of PubBio.co, profiles a small cap that "is poised to bring to clinic a next-generation of must-have cystoscopy equipment."

A Solace to the Stress of the SolarWinds Hack
Source: Jack Hurley for Streetwise Reports (01/21/2021)

Against the backdrop of the massive SolarWinds hack, value investor Jack Hurley discusses his investment thesis for Leonovus Inc, whose products provide an "ironclad level of cybersecurity."

Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports (01/15/2021)

Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.

Neurosciences Firm Outlines Strategic Priorities for 2021
Source: Streetwise Reports (01/15/2021)

ProMIS Neurosciences discusses its four priority areas in 2021.

This Tiny Digital Healthcare Company's Sales Should Rocket Higher
Source: Matt Badiali for Streetwise Reports (01/06/2021)

Independent financial analyst Matt Badiali profiles a small cap whose blood glucose monitoring system works with any smartphone.

This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality
Source: Matt Badiali for Streetwise Reports (01/05/2021)

Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic.

DermTech Shares Rise 32% on Geisinger Health Support for Skin Cancer Test
Source: Streetwise Reports (12/30/2020)

Shares of DermTech Inc. climbed to a new 52-week high after the company reported it has received positive medical coverage by Geisinger Health System for its pigmented lesion assay, a non-invasive test for detecting melanoma.

California Biotech Advances Two COVID-19 Products
Source: Streetwise Reports (12/30/2020)

Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report.

BioTelemetry Shares Beat Higher on Royal Philips $2.8 Billion Buyout Offer
Source: Streetwise Reports (12/18/2020)

Shares of BioTelemetry Inc. rise 16.5% to a new 52-week high after Royal Philips agreed to acquire the company for US$2.8 billion, or US$72.00 per share in an all cash transaction.